NCT01130402

Brief Summary

The investigaotors want to establish a real-time and computerized score reporting system based on the significant predictors of the measured sonographic parameters and demographic data.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
189

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2009

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2009

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2009

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 24, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 26, 2010

Completed
Last Updated

May 26, 2010

Status Verified

April 1, 2009

First QC Date

May 24, 2010

Last Update Submit

May 25, 2010

Conditions

Keywords

agelymphadenopathyfine needle aspirationsonography

Outcome Measures

Primary Outcomes (1)

  • The final diagnoses of lymph nodes were made by US-FNA cytological studies, pathologic results of the biopsy specimens, or at least 3 months of negative follow-up observations.

    3 months

Study Arms (1)

Neck masses

Patients with previously untreated neck masses

Eligibility Criteria

Age10 Years - 83 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with previously untreated neck masses were referred for sonographic evaluation and subsequent US-FNA after informed consent was obtained. Demographic data, including age and sex, side, site, and number of lymphadenopathy was collected as well.

You may qualify if:

  • Patients with previously untreated neck masses underwent neck US

You may not qualify if:

  • The neck mass was not lymph node
  • No US-FNA cytology result

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Far Eastern Memorial Hospital

Taipei, 22050, Taiwan

Location

Related Publications (1)

  • Liao LJ, Wang CT, Young YH, Cheng PW. Real-time and computerized sonographic scoring system for predicting malignant cervical lymphadenopathy. Head Neck. 2010 May;32(5):594-8. doi: 10.1002/hed.21225.

MeSH Terms

Conditions

Lymphadenopathy

Condition Hierarchy (Ancestors)

Lymphatic DiseasesHemic and Lymphatic Diseases

Study Officials

  • Li-Jen Liao, MD

    Department of Otolaryngology, Far Eastern Memorial Hospital, Taipei, Taiwan

    STUDY DIRECTOR

Study Design

Study Type
observational
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 24, 2010

First Posted

May 26, 2010

Study Start

June 1, 2009

Study Completion

September 1, 2009

Last Updated

May 26, 2010

Record last verified: 2009-04

Locations